Lilly 4Q09 4Q Revenues: $5.9 billion (+14%) 4Q Earnings: $915.4 million (loss of $3.6 billion in 4Q08) FY Revenues: $21.8 billion (+7%) FY Earnings: $4.3 billion (loss of $2.1 billion in FY09) Comments: Earnings in 4Q08 were affected by a $4.7 billion charge related to the ImClone acquisition. Lilly incurred charges of $692.7 million in FY09 for restructuring and Zyprexa litigation. Zyprexa sales rose 19% in 4Q09 to $1.4 billion and 5% in FY09 to $4.9 billion, with a 4Q09 internat...